Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yao An

Showing results (101-110 of 125) with videos related to

Pageof 13
Sort By:
Frontiers in Genetics|September 14, 2020
Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics AnalysisYu-Peng Wu, Xiao-Dan Lin, Shao-Hao Chen, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I InhibitorLin-Yu Chen, Yao-An Shen, Ling-Hui Chu, et al.
Iscience|November 24, 2021
Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategyYao-An Shen, Jin Jung, Geoffrey D Shimberg, et al.
Nanoscale|April 14, 2026
Targeting glutamine metabolism combined with a nanoradioenhancer in radioresistant hepatocellular carcinomaChia-Chun Kuo, Yao-Chen Chuang, Ping-Hsiu Wu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 16, 2024
Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancerShiho Asaka, Neha Verma, Ting-Tai Yen, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistanceTing-Wan Kao, Geng-Hao Bai, Tian-Li Wang, et al.
Nature Communications|October 5, 2024
A fair individualized polysocial risk score for identifying increased social risk in type 2 diabetesYu Huang, Jingchuan Guo, William T Donahoo, et al.
JAMA Oncology|August 21, 2025
GLP-1 Receptor Agonists and Cancer Risk in Adults With ObesityHao Dai, Yongqiu Li, Yao An Lee, et al.
International Journal of Nanomedicine|April 8, 2015
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor controlYao An Shen, Ing Luen Shyu, Maggie Lu, et al.
Pathology, Research and Practice|August 28, 2020
Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysisYu-Peng Wu, Zhi-Bin Ke, Fei Lin, et al.
Pageof 13

Showing results (101-110 of 125) with videos related to

Sort By:
Pageof 13
Frontiers in Genetics|September 14, 2020
Identification of Prostate Cancer-Related Circular RNA Through Bioinformatics AnalysisYu-Peng Wu, Xiao-Dan Lin, Shao-Hao Chen, et al.
Antioxidants (Basel, Switzerland)|June 27, 2024
Active DNA Demethylase, TET1, Increases Oxidative Phosphorylation and Sensitizes Ovarian Cancer Stem Cells to Mitochondrial Complex I InhibitorLin-Yu Chen, Yao-An Shen, Ling-Hui Chu, et al.
Iscience|November 24, 2021
Development of small molecule inhibitors targeting PBX1 transcription signaling as a novel cancer therapeutic strategyYao-An Shen, Jin Jung, Geoffrey D Shimberg, et al.
Nanoscale|April 14, 2026
Targeting glutamine metabolism combined with a nanoradioenhancer in radioresistant hepatocellular carcinomaChia-Chun Kuo, Yao-Chen Chuang, Ping-Hsiu Wu, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 16, 2024
Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancerShiho Asaka, Neha Verma, Ting-Tai Yen, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 17, 2023
Novel cancer treatment paradigm targeting hypoxia-induced factor in conjunction with current therapies to overcome resistanceTing-Wan Kao, Geng-Hao Bai, Tian-Li Wang, et al.
Nature Communications|October 5, 2024
A fair individualized polysocial risk score for identifying increased social risk in type 2 diabetesYu Huang, Jingchuan Guo, William T Donahoo, et al.
JAMA Oncology|August 21, 2025
GLP-1 Receptor Agonists and Cancer Risk in Adults With ObesityHao Dai, Yongqiu Li, Yao An Lee, et al.
International Journal of Nanomedicine|April 8, 2015
Bypassing the EPR effect with a nanomedicine harboring a sustained-release function allows better tumor controlYao An Shen, Ing Luen Shyu, Maggie Lu, et al.
Pathology, Research and Practice|August 28, 2020
Identification of key genes and pathways in castrate-resistant prostate cancer by integrated bioinformatics analysisYu-Peng Wu, Zhi-Bin Ke, Fei Lin, et al.
Pageof 13